Does night work put women’s health at risk?

 

Paris, France (June 19, 2012) – Breast cancer is the number one cause of female mortality. It affects 100 out of 100,000 women per year in developed countries. Each year, more than 1.3 million new cases are diagnosed, 53,000 of these in France. The risk factors of breast cancer are varied. They include genetic mutations, late first pregnancy, low parity or hormone therapy, but other causes of breast cancer such as way of life, environmental or professional causes have not yet been completely identified.

 

In 2010, based on experimental and epidemiological work, the International Agency for Research on Cancer (IARC) classified work that disturbed the circadian rhythm as being "probably carcinogenic". The circadian rhythm, that regulates the alternation between wakefulness and sleep, controls numerous biological functions and is altered in people who work at night or who have disrupted working hours. Several hypotheses have been put forward to explain the observed links between night work and breast cancer: exposure to light during the night, that eliminates the nocturnal melatonin surge and its anti-carcinogenic effects, disturbed functioning of the biological clock genes that control cell proliferation, or sleep disorders that can weaken the immune system.

 

So the Inserm researchers examined the effect of night work on the health of women in a major population study carried out in France between 2005 and 2008. The careers of 3000 women were examined, including each period of night work. In total, over 11% of women had worked nights at some time during their career.

 

The risk of developing breast cancer was 30% higher in women who had worked nights compared to women who had never worked nights. This increased risk was particularly marked in women who had worked nights for over four years, or in women whose working rhythm was less than 3 nights per week, because this led to more frequent disturbances between night and day rhythms.

 

Finally, the link between night work and breast cancer seemed to be more marked when we looked at women who had worked at night prior to a first pregnancy. An explanation for this result could be that the mammary cells, incompletely differentiated in women before their first pregnancy, are more vulnerable.

 

"Our work has corroborated the results of previous studies and poses the problem of taking night work into consideration in public health management, especially since the number of women working atypical hours is on the increase", states Pascal Guénel, the main author of this work.

 

 

Sources

 

  • Night work and breast cancer: a population-based case-control study in France (the CECILE study) Florence Menegaux1,2, Thérèse Truong1,2, Antoinette Anger1,2, Emilie Cordina-Duverger1,2, Farida Lamkarkach1,2, Patrick Arveux3, Pierre Kerbrat4, Joëlle Févotte5, Pascal Guénel1,2,5
    1 Inserm, CESP Centre for research in Epidemiology and Population Health, U1018, Environmental Epidemiology of Cancer, F-94807, Villejuif, France
    2 Univ Paris-Sud, UMRS 1018, F-94807, Villejuif, France
    3 Centre Georges-François Leclerc, Département d’informatique médicale (Department of medical informatics), Dijon, France
    4 Centre Eugène Marquis, Rennes, France
    5 Institut de Veille Sanitaire (Health watch institute) (InVS), Department of Occupational Health, Saint-Maurice, France
    International Journal of Cancer http://onlinelibrary.wiley.com/doi/10.1002/ijc.27669/abstract

 


 

INSERM (Institut national de la santé et de la recherche médicale), 19.06.2012 (tB).

MEDICAL NEWS

COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…
Suliqua®: In komplexem Umfeld – einfach besser eingestellt
Suliqua®: Überlegene HbA1c-Senkung  im Vergleich zu Mischinsulinanalogon
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 

ERNÄHRUNG

Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen

ONKOLOGIE

Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
WHO veröffentlicht erste Klassifikation von Tumoren im Kindesalter
Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!

MULTIPLE SKLEROSE

Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…
Stellungnahme zur 3. Impfung gegen SARS-CoV2 bei Personen mit MS
NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…